U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C22H25N3O4
Molecular Weight 395.4516
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ABANOQUIL

SMILES

COC1=CC2=C(C=C1OC)C(N)=CC(=N2)N3CCC4=CC(OC)=C(OC)C=C4C3

InChI

InChIKey=ANZIISNSHPKVRV-UHFFFAOYSA-N
InChI=1S/C22H25N3O4/c1-26-18-7-13-5-6-25(12-14(13)8-19(18)27-2)22-10-16(23)15-9-20(28-3)21(29-4)11-17(15)24-22/h7-11H,5-6,12H2,1-4H3,(H2,23,24)

HIDE SMILES / InChI

Description

Abanoquil (UK-52,046), an antiarrhythmic drug, is an alpha 1-adrenoceptor antagonist, has been studied for the treatment of erectile dysfunction.

Approval Year

Unknown
149,124

Targets

Primary TargetPharmacologyConditionPotency
Adrenergic receptor alpha-1
171
Antagonist
2,849

PubMed

Patents

JPS6440425A
3

Sample Use Guides

In Vivo Use Guide
single oral doses of abanoquil 0.25, 0.5 and 1 mg
Route of Administration: Oral
ACTIVE MOIETY
Structure of ABANOQUIL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966